Navigation Links
Chiltern Acquires Brazil-Based Clinical Research Organization Vigiun
Date:4/17/2009

LONDON, April 17 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas and India, today announced the acquisition of Vigiun, a full service Clinical Research Organization located in Sao Paulo, Brazil.

Established in 1999 by Eduardo Forleo, MD, and Elisa Halker, BSN, Vigiun has extensive experience conducting clinical trials in a variety of therapeutic areas, in particular infectious disease, oncology, and respiratory.

"We warmly welcome Vigiun to the Chiltern team," stated John Vann, Executive Vice President, Americas. "The acquisition of Vigiun enhances Chiltern's growing presence in Latin America, which was established nearly a year ago when we began operations in Argentina under the leadership of Oscar Podesta, our General Manager for Latin America. The knowledge and experience of Eduardo Forleo and Elisa Halker, and all of the Vigiun staff, will further strengthen our ability to serve our clients and continue our strategy for growth in the region."

Dr. Forleo has been appointed Chiltern's Country Manager for Brazil and Medical Director for Latin America. Ms.Halker will serve as Director of Clinical Operations for Brazil.

Said Dr. Forleo, "This is an exciting time to become a part of Chiltern. Our business has grown to the point that it makes sense to join forces with a global CRO whose mission and values align with ours. I look forward to contributing in very positive ways to the company's ongoing and future success."

"I am very pleased to have Vigiun join Chiltern," said Glenn Kerkhof, Chiltern's CEO. "Vigiun is an ideal complement to our existing Latin American operations and Chiltern's presence in 27 other countries as we serve the pharmaceutical and biotech industries globally."

Latin America has a population of 503 million people, of which 192 million are in Brazil. This vast population provides a significant number of potential patients in all disease areas. Latin America is rich with experienced investigators and is known for high quality data and excellent patient retention in clinical trials.

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 28 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.

    For More Information Contact:

    Mac McElroy                       Stuart McGuire
    Chiltern International Inc.       Chiltern International Ltd.
    1241 Volunteer Parkway            171 Bath Road
    Suite 950                         Slough
    Bristol, TN 37620                 Berkshire SL1 4AA
    USA                               UNITED KINGDOM
    Tel: +1 (423) 968 9533            Tel: +44 (0) 1753 512 000
    Fax: +1 (423) 968 3567            Fax: +44 (0) 1753 511 116
    Email: mac.mcelroy@chiltern.com   Email: stuart.mcguire@chiltern.com


'/>"/>
SOURCE Chiltern International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marco Romano, MD Joins Chiltern as Medical Director, Europe
2. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
3. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
4. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
5. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Chiltern Wins Top Prize
8. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
9. Chiltern Opens a New Office in Russia
10. Chiltern Announces New Expansion in Portugal
11. Chiltern Expands Its Global Reach to Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
(Date:2/8/2016)... Palatin Technologies, Inc. (NYSE MKT: PTN), ... for the treatment of diseases with significant unmet ... the United States Patent and Trademark Office (USPTO) ... Patent Application Serial Number 14/313,258 (the ,258 application).  ... female sexual dysfunction using the formulation and dose ...
Breaking Medicine Technology: